Turner R T, Puzas J E, Forte M D, Lester G E, Gray T K, Howard G A, Baylink D J
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5720-4. doi: 10.1073/pnas.77.10.5720.
The question of whether the skeleton metabolizes 25-hydroxycholecalciferol [25(OH)D3] to more-polar products was studied. Calvarial cells were dispersed from 16-day old chicken embryos by using collagenase and then grown in culture in serum-free medium. Confluent cell cultures were incubated with 7 nM 25(OH)[3H]D3 for 2 hr, and the vitamin D metabolites were then extracted. At least four polar metabolites were produced. Based on separation by Sephadex LH-20 chromatography followed by high-pressure liquid chromatography, two of these metabolites were identified as 1,25-dihydroxycholecalciferol [1,25(OH)2D3] and 24,25-dihydroxycholecalciferol [24,25(OH)2D3]. These metabolites were also produced by cultured kidney cells but not by liver, heart muscle, or skin cells isolated from the same embryos. The specific activities of the calvarial 1- and 24-hydroxylases were similar in magnitude to those in isolated kidney cells. The specific activity of the calvarial 25(OH)D3:1-hydroxylase was inhibited by an 8-hr preincubation with 1,25(OH)2D3, whereas the 24-hydroxylase was enhanced. It is concluded that (i) vitamin D metabolism by isolated cells is organ-specific, (ii) calvarial cells produce active metabolites of vitamin D in significant amounts, (iii) vitamin D metabolism by calvarial cells is regulated by 1,25(OH)2D3, and (iv) locally produced, active metabolites could act locally, thereby adding a new dimension to the regulation of mineral metabolism by vitamin D metabolites.
研究了骨骼是否将25-羟基胆钙化醇[25(OH)D3]代谢为极性更强的产物。通过使用胶原酶从16日龄鸡胚中分离出颅盖细胞,然后在无血清培养基中进行培养。汇合的细胞培养物与7 nM 25(OH)[3H]D3孵育2小时,然后提取维生素D代谢产物。至少产生了四种极性代谢产物。基于葡聚糖LH-20柱色谱分离后再进行高压液相色谱分析,其中两种代谢产物被鉴定为1,25-二羟基胆钙化醇[1,25(OH)2D3]和24,25-二羟基胆钙化醇[24,25(OH)2D3]。这些代谢产物也由培养的肾细胞产生,但从同一胚胎分离的肝、心肌或皮肤细胞则不会产生。颅盖细胞1-羟化酶和24-羟化酶的比活性与分离的肾细胞中的比活性大小相似。颅盖细胞25(OH)D3:1-羟化酶的比活性在与1,25(OH)2D3预孵育8小时后受到抑制,而24-羟化酶的比活性则增强。得出的结论是:(i) 分离细胞的维生素D代谢具有器官特异性;(ii) 颅盖细胞能大量产生维生素D的活性代谢产物;(iii) 颅盖细胞的维生素D代谢受1,25(OH)2D3调节;(iv) 局部产生的活性代谢产物可在局部发挥作用,从而为维生素D代谢产物对矿物质代谢的调节增添了新的维度。